These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase. Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731 [TBL] [Abstract][Full Text] [Related]
23. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410 [TBL] [Abstract][Full Text] [Related]
24. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma. Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543 [TBL] [Abstract][Full Text] [Related]
26. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells. Namba H; Tagawa M; Iwadate Y; Kimura M; Sueyoshi K; Sakiyama S Hum Gene Ther; 1998 Jan; 9(1):5-11. PubMed ID: 9458237 [TBL] [Abstract][Full Text] [Related]
27. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene. Rosenfeld ME; Vickers SM; Raben D; Wang M; Sampson L; Feng M; Jaffee E; Curiel DT Ann Surg; 1997 May; 225(5):609-18; discussion 618-20. PubMed ID: 9193188 [TBL] [Abstract][Full Text] [Related]
28. Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo. Zhang L; Wikenheiser KA; Whitsett JA Hum Gene Ther; 1997 Mar; 8(5):563-74. PubMed ID: 9095408 [TBL] [Abstract][Full Text] [Related]
29. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma. Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892 [TBL] [Abstract][Full Text] [Related]
30. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma]. Zhao Y; Zhang X; Hui H Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424 [TBL] [Abstract][Full Text] [Related]
31. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells. Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379 [TBL] [Abstract][Full Text] [Related]
32. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma]. He J; Chen Y; Li H; Lu Y; Yan Y; Tan X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149 [TBL] [Abstract][Full Text] [Related]
33. Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells. Vrionis FD; Wu JK; Qi P; Cano WG; Cherington V J Neurooncol; 1996 Dec; 30(3):225-36. PubMed ID: 8943097 [TBL] [Abstract][Full Text] [Related]
34. Herpes simplex virus thymidine kinase and ganciclovir suicide gene therapy for human pancreatic cancer. Wang J; Lu XX; Chen DZ; Li SF; Zhang LS World J Gastroenterol; 2004 Feb; 10(3):400-3. PubMed ID: 14760766 [TBL] [Abstract][Full Text] [Related]
35. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129 [TBL] [Abstract][Full Text] [Related]
36. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea. Boucher PD; Ostruszka LJ; Shewach DS Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133 [TBL] [Abstract][Full Text] [Related]
37. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy. Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868 [TBL] [Abstract][Full Text] [Related]
38. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection. Janousková O; Síma P; Kunke D Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310 [TBL] [Abstract][Full Text] [Related]
39. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice. Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117 [TBL] [Abstract][Full Text] [Related]
40. Cooperative therapeutic effects of herpes simplex virus thymidine kinase gene/ganciclovir system and chemotherapeutic agents on prostate cancer in vitro. Xing Y; Xiao Y; Lu G; Zeng F; Zhao J; Xiong P; Feng W J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):610-3. PubMed ID: 17219983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]